ID-IRI

ID-IRI S. maltophilia in the ICUs, published

Dear Members of the ID-IRI Community

The ID-IRI Stenotrophomonas maltophilia ICU infections in the ICUs, using a prospective design (Oct 2023–Apr 2024, 36 ICUs in 12 countries) evaluating 207 adult patients got paginated. [J Infect Dev Ctries 2026; 20(3):398-406] https://jidc.org/index.php/journal/article/view/22056

 The infection a high 30-day mortality rate of 52.7%, mainly associated with bloodstream infections (38%) and pneumonia (28.5%); resistance rates were relatively low for trimethoprim-sulfamethoxazole (7.2%) and levofloxacin (10.4%) but higher for ceftazidime (27%), and notably, no patients received effective empiric therapy,

Independent risk factors for mortality included

1.     Older age

2.     Acute renal failure

3.     COPD

4.     Malignancy

5.     qSOFA ≥ 2

Independent risk factors for survival included

1.     Repeat culturing

2.     Antimicrobial adjustment based on susceptibility  

Unknown's avatar

Published by ID-IRI

EXECUTIVE PROFILE I was born in 1969 in Seydişehir, Turkey in 1969. I became a general practitioner after graduation from GATA medical faculty in 1993 and worked as a general practitioner between 1994 and 1996. I have performed my fellowship in GATA Haydarpasa Training Hospital, Department of Infectious Diseases and Clinical Microbiology in Istanbul during 1996-2000. I worked as infectious diseases specialists in Sivas Hospital during 2000-2003. I became an assistant professor in Gulhane Academy in a 2003, and an associate professor in 2006. I worked as the chief of Infectious Diseases and Clinical Microbiology Department in GATA Haydarpasa Hospital in Istanbul between July 2014 and July 2015. I became a Professor at June 2015. SKILL HIGHLIGHTS Clinical teacher, lecturer An experienced clinician in the field of infectious diseases Experience in ICU infections Experience in community acquired infections Multinational/multicenter clinical research management The founder and lead coordinator of ID-IRI, which is likely to be the largest clinical research platform in the world (https://infectdisiri.wordpress.com/) Experience in scientific activities of European Society for Clinical Microbiology and Infectious Diseases (ESCMID) and other societies Active memberships in ESGIB, ESGITM, ESGCIP PROFESSIONAL EXPERIENCE I worked in the field of infectious diseases and clinical microbiology since 1996 and performed many clinical researches since then. I have founded ID-IRI, an international research platform in 2008. We have performed many multicentric/multinational projects through ID-IRI since then. INTERNATIONAL AWARDS In April 24, 2017, I was awarded with the merit-based “ESCMID Fellow” title by European Society of Clinical Microbiology and Infectious Diseases (ESCMID) executive committee. This title recognizes individuals who have achieved professional excellence and rendered outstanding service to the profession and the society.

Leave a comment